End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-21 pm EDT
|
5-day change
|
1st Jan Change
|
6.76
CNY
|
+0.15%
|
|
-0.44%
|
-18.06%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,007
|
2,940
|
3,187
|
3,698
|
3,139
|
3,099
|
Enterprise Value (EV)
1 |
3,132
|
2,902
|
3,145
|
3,866
|
3,745
|
3,618
|
P/E ratio
|
11.6
x
|
31.9
x
|
21.6
x
|
12.5
x
|
79.7
x
|
31.4
x
|
Yield
|
2.77%
|
0.51%
|
1%
|
2.15%
|
0.19%
|
1.66%
|
Capitalization / Revenue
|
1.16
x
|
1.03
x
|
1.33
x
|
0.98
x
|
0.7
x
|
0.68
x
|
EV / Revenue
|
1.21
x
|
1.02
x
|
1.32
x
|
1.03
x
|
0.83
x
|
0.79
x
|
EV / EBITDA
|
8.73
x
|
18.7
x
|
13.1
x
|
9.35
x
|
29.8
x
|
16.3
x
|
EV / FCF
|
-29.9
x
|
-27.6
x
|
-578
x
|
-22.4
x
|
-11.7
x
|
32.2
x
|
FCF Yield
|
-3.34%
|
-3.62%
|
-0.17%
|
-4.46%
|
-8.55%
|
3.11%
|
Price to Book
|
2.04
x
|
1.64
x
|
1.65
x
|
1.67
x
|
1.42
x
|
1.34
x
|
Nbr of stocks (in thousands)
|
333,329
|
375,436
|
375,438
|
375,440
|
375,444
|
375,686
|
Reference price
2 |
9.020
|
7.830
|
8.490
|
9.850
|
8.360
|
8.250
|
Announcement Date
|
4/25/19
|
4/28/20
|
4/29/21
|
4/28/22
|
4/28/23
|
4/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,587
|
2,856
|
2,391
|
3,759
|
4,504
|
4,563
|
EBITDA
1 |
358.8
|
155.5
|
239.1
|
413.3
|
125.5
|
221.4
|
EBIT
1 |
322.5
|
104.4
|
185.9
|
359
|
68.18
|
141.4
|
Operating Margin
|
12.47%
|
3.66%
|
7.77%
|
9.55%
|
1.51%
|
3.1%
|
Earnings before Tax (EBT)
1 |
315.2
|
94.56
|
176.2
|
350.7
|
39.32
|
111.7
|
Net income
1 |
277.9
|
91.04
|
158.2
|
317.2
|
39.38
|
101.4
|
Net margin
|
10.74%
|
3.19%
|
6.62%
|
8.44%
|
0.87%
|
2.22%
|
EPS
2 |
0.7760
|
0.2457
|
0.3934
|
0.7883
|
0.1049
|
0.2630
|
Free Cash Flow
1 |
-104.6
|
-105.1
|
-5.439
|
-172.5
|
-320.3
|
112.4
|
FCF margin
|
-4.04%
|
-3.68%
|
-0.23%
|
-4.59%
|
-7.11%
|
2.46%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
50.78%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
110.92%
|
Dividend per Share
2 |
0.2500
|
0.0400
|
0.0850
|
0.2120
|
0.0160
|
0.1370
|
Announcement Date
|
4/25/19
|
4/28/20
|
4/29/21
|
4/28/22
|
4/28/23
|
4/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
126
|
-
|
-
|
168
|
606
|
519
|
Net Cash position
1 |
-
|
37.2
|
42.8
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.3503
x
|
-
|
-
|
0.4055
x
|
4.832
x
|
2.342
x
|
Free Cash Flow
1 |
-105
|
-105
|
-5.44
|
-172
|
-320
|
112
|
ROE (net income / shareholders' equity)
|
20.6%
|
5.57%
|
8.49%
|
15.3%
|
1.78%
|
4.5%
|
ROA (Net income/ Total Assets)
|
10.8%
|
2.98%
|
4.71%
|
8.33%
|
1.37%
|
2.68%
|
Assets
1 |
2,582
|
3,056
|
3,356
|
3,807
|
2,865
|
3,789
|
Book Value Per Share
2 |
4.420
|
4.780
|
5.150
|
5.910
|
5.870
|
6.140
|
Cash Flow per Share
2 |
0.4900
|
0.4800
|
0.3900
|
0.4400
|
0.2800
|
0.4900
|
Capex
1 |
207
|
68.6
|
80.7
|
203
|
79.1
|
69.1
|
Capex / Sales
|
7.99%
|
2.4%
|
3.37%
|
5.4%
|
1.76%
|
1.51%
|
Announcement Date
|
4/25/19
|
4/28/20
|
4/29/21
|
4/28/22
|
4/28/23
|
4/28/24
|
|
1st Jan change
|
Capi.
|
---|
| -18.06% | 346M | | +3.15% | 104B | | -8.02% | 62.39B | | +72.86% | 48.95B | | +18.82% | 39.58B | | +3.62% | 32.08B | | +12.35% | 20.22B | | +13.00% | 16.86B | | +16.25% | 14.88B | | +2.22% | 13.99B |
Other Commodity Chemicals
|